Clinical practice guidelines: The good, the bad, and the ugly

Published:January 31, 2022DOI:


      Clinical practices guidelines (CPGs) play a fundamental role in improving healthcare and patients’ outcomes by helping clinicians make the best evidence-based decisions for their patients in a time-efficient manner. By following the available methods and criteria to create trustworthy CPGs, panel members can develop high-quality guidelines. However, despite the improvements over the years, CPGs are still subjected to biases and limitations, with conflicts of interest being the ugliest problem GCPs must face. In this review, we discuss the main characteristics of clinical practice guidelines, their pros and cons, and the future challenges they need to overcome.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Injury
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines
        Clinical practice guidelines we can trust.
        National Academies Press, Washington, D.C.2011
        • Woolf SH
        • Grol R
        • Hutchinson A
        • Eccles M
        • Grimshaw J.
        Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines.
        BMJ. 1999; 318: 527-530
        • Murad MH.
        Clinical practice guidelines: a primer on development and dissemination.
        Mayo Clin Proc. 2017; 92: 423-433
        • Gagliardi AR
        • Marshall C
        • Huckson S
        • James R
        • Moore V.
        Developing a checklist for guideline implementation planning: review and synthesis of guideline development and implementation advice.
        Implement Sci. 2015; 10: 19
        • Woolf SH.
        Practice guidelines, a new reality in medicine.
        Arch Intern Med. 1992; 152: 946
        • Guyatt G.
        Evidence-based medicine (editorial).
        ACP J Club. 1991; 114: A16
        • Medicine Institute of
        Clinical practice guidelines.
        National Academies Press, Washington, D.C.1990
        • Shaneyfelt TM
        • Centor RM.
        Reassessment of clinical practice guidelines.
        JAMA. 2009; 301: 868
        • Guyatt G
        • Rennie D
        • Meade MO
        • Cook DJ.
        Users’ guides to the medical literature. A manual for evidence-based clinical practice.
        3r ed. JAMA Evidence, 2015
        • Shekelle PG
        • Ortiz E
        • Rhodes S
        • Morton SC
        • Eccles MP
        • Grimshaw JM
        • et al.
        Validity of the agency for healthcare research and quality clinical practice guidelines.
        JAMA. 2001; 286: 1461
        • Evidence-Based Medicine Working Group
        Evidence-based medicine. A new approach to teaching the practice of medicine.
        JAMA. 1992; 268: 2420-2425
      1. What is GRADE? | BMJ Best Practice [Internet].
        2021 ([citedOct 29]. Available from:)
        • Neumann I
        • Santesso N
        • Akl EA
        • Rind DM
        • Vandvik PO
        • Alonso-Coello P
        • et al.
        A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach.
        J Clin Epidemiol. 2016; 72: 45-55
        • Brouwers MC
        • Kho ME
        • Browman GP
        • Burgers JS
        • Cluzeau F
        • Feder G
        • et al.
        AGREE II: advancing guideline development, reporting, and evaluation in health care.
        Prev Med. 2010; 51: 421-424
        • Brouwers MC
        • Kerkvliet K
        • Spithoff K
        • Consortium ANS.
        The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines.
        BMJ. 2016; 352: i1152
        • Busse JW
        • Bhandari M
        • Einhorn TA
        • Schemitsch E
        • Heckman JD
        • et al.
        • TRUST Investigators writing group
        Re-evaluation of low intensity pulsed ultrasound in treatment of tibial fractures (TRUST): randomized clinical trial.
        BMJ. 2016; 355: i5351
        • Schandelmaier S
        • Kaushal A
        • Lytvyn L
        • Heels-Ansdell D
        • Siemieniuk RAC
        • Agoritsas T
        • et al.
        Low intensity pulsed ultrasound for bone healing: systematic review of randomized controlled trials.
        BMJ. 2017; 356: j656
        • Poolman RW
        • Agoritsas T
        • Siemieniuk RAC
        • Harris IA
        • Schipper IB
        • Mollon B
        • et al.
        Low intensity pulsed ultrasound (LIPUS) for bone healing: a clinical practice guideline.
        BMJ. 2017; 356: j576
        • Iannone P
        • Montano N
        • Minardi M
        • Doyle J
        • Cavagnaro P
        • Cartabellotta A.
        Wrong guidelines: why and how often they occur.
        Evid Based Med. 2017; : 1-3
        • Kung J
        • Miller RR
        • Mackowiak PA.
        Failure of clinical practice guidelines to meet institute of medicine standards: Two more decades of little, if any, progress.
        Arch Intern Med. 2012; 172: 1628-1633
        • Institute of Medicine (US) Committee to Advise the Public Health Service on Clinical Practice Guidelines
        Field MJ Lohr KN Clinical practice guidelines: directions for a new program. National Academies Press (US), Washington (DC)1990
        • Franco JVA
        • Arancibia M
        • Meza N
        • Madrid E
        • Kopitowski K.
        Clinical practice guidelines: Concepts, limitations and challenges.
        Medwave. 2020; 20: e7887
        • Dumbreck S
        • Flynn A
        • Nairn M
        • Wilson M
        • Treweek S
        • Mercer SW
        • et al.
        Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines.
        BMJ. 2015; 350: h949
        • Paraskevas KI
        • Mikhailidis DP
        • Veith FJ.
        Comparison of the five 2011 guidelines for the treatment of carotid stenosis.
        J Vasc Surg. 2012; 55: 1504-1508
        • Wyatt KD
        • Stuart LM
        • Brito JP
        • Leon BC
        • Domecq JP
        • Prutsky GJ
        • et al.
        Out of context: clinical practice guidelines and patients with multiple chronic conditions a systematic review.
        Med Care. 2014; 52: 92-100
        • Martínez García L
        • Sanabria AJ
        • García Álvarez E
        • Trujillo-Martín MM
        • Etxeandia-Ikobaltzeta I
        • Kotzeva A
        • et al.
        The validity of recommendations from clinical guidelines: A survival analysis.
        Cmaj. 2014; 186: 1211-1219
        • Shekelle P
        • Woolf S
        • Grimshaw JM
        • Schünemann HJ
        • Eccles MP.
        Developing clinical practice guidelines: reviewing, reporting, and publishing guidelines; updating guidelines; and the emerging issues of enhancing guideline implementability and accounting for comorbid conditions in guideline development.
        Implement Sci. 2012; 7: 62
        • Montori VM
        • Guyatt GH.
        Corruption of the evidence as threat and opportunity for evidence-based medicine.
        Harvard Health Policy Rev. 2007; 8: 145-155
        • Cosgrove L
        • Krimsky S
        • Wheeler EE
        • Peters SM
        • Brodt M
        • Shaughnessy AF.
        Conflict of interest policies and industry relationships of guideline development group members: a cross-sectional study of clinical practice guidelines for depression.
        Account Res. 2017; 24: 99-115
        • Sprung CL.
        Randomized controlled trials and practice guidelines: the good, the bad, and the ugly.
        Intensive Care Med. 2012; 38: 1911-1913
        • Institute of Medicine (US)
        Committee on conflict of interest in medical research, education and P. conflict of interest in medical research, education, and practice.
        National Academies Press, Washington, DC, US2009
        • Choudhry NK.
        Relationships between authors of clinical practice guidelines and the pharmaceutical industry.
        JAMA. 2002; 287: 612
        • Khan R
        • Scaffidi MA
        • Rumman A
        • Grindal AW
        • Plener IS
        • Grover SC.
        Prevalence of financial conflicts of interest among authors of clinical guidelines related to high-revenue medications.
        JAMA Intern Med. 2018; 178: 1712
        • Tabatabavakili S
        • Khan R
        • Scaffidi MA
        • Gimpaya N
        • Lightfoot D
        • Grover SC.
        Financial conflicts of interest in clinical practice guidelines: a systematic review.
        Mayo Clin Proc Innov Qual Outcomes. 2021; 5: 466-475
        • Neuman J
        • Korenstein D
        • Ross JS
        • Keyhani S.
        Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study.
        BMJ. 2011; 343 (d5621–d5621)
        • Elder K
        • Turner KA
        • Cosgrove L
        • Lexchin J
        • Shnier A
        • Moore A
        • et al.
        Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study.
        Can Med Assoc J. 2020; 192: E617-E625
        • Roberts CS
        • Battista CT.
        Conflict of interest vs. competition of interest in orthopaedic surgery.
        Injury. 2011; 42: 615-616
        • Alia E
        • Grant-Kels JM
        The trustworthiness and transparency in clinical practice guidelines versus the ongoing damaging power of direct and indirect conflict of interest.
        Clin Dermatol. 2020; 38: 254-256
        • Campsall P
        • Colizza K
        • Straus S
        • Stelfox HT.
        Financial relationships between organizations that produce clinical practice guidelines and the biomedical industry: a cross-sectional study.
        PLOS Med. 2016; 13e1002029